Company profile NBY

Novabay Pharmaceuticals Inc
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerxâ„...¢ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across Show More
Quarter analysis & expected interest

There is not enough data for NovaBay Pharmaceuticals - Avenova Spray to provide analysis

Correlation between past revenue and NovaBay Pharmaceuticals - Avenova Spray search interest

There is not enough data for NovaBay Pharmaceuticals - Avenova Spray to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NovaBay Pharmaceuticals - Avenova Spray to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NeutroPhase wound care products to provide analysis

Correlation between past revenue and NeutroPhase wound care products search interest

There is not enough data for NeutroPhase wound care products to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NeutroPhase wound care products to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for PhaseOne wound care products to provide analysis

Correlation between past revenue and PhaseOne wound care products search interest

There is not enough data for PhaseOne wound care products to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for PhaseOne wound care products to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for DERMAdoctor skincare solutions to provide analysis

Correlation between past revenue and DERMAdoctor skincare solutions search interest

There is not enough data for DERMAdoctor skincare solutions to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DERMAdoctor skincare solutions to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NovaBay Pharmaceuticals products to provide analysis

Correlation between past revenue and NovaBay Pharmaceuticals products search interest

There is not enough data for NovaBay Pharmaceuticals products to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NovaBay Pharmaceuticals products to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NovaBay Pharmaceuticals login to provide analysis

Correlation between past revenue and NovaBay Pharmaceuticals login search interest

There is not enough data for NovaBay Pharmaceuticals login to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NovaBay Pharmaceuticals login to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NovaBay Pharmaceuticals contact to provide analysis

Correlation between past revenue and NovaBay Pharmaceuticals contact search interest

There is not enough data for NovaBay Pharmaceuticals contact to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NovaBay Pharmaceuticals contact to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for NovaBay Pharmaceuticals careers to provide analysis

Correlation between past revenue and NovaBay Pharmaceuticals careers search interest

There is not enough data for NovaBay Pharmaceuticals careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for NovaBay Pharmaceuticals careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 20:09:46.

After 39 days of this quarter the interest is at 21.0. Based on that we can calculate that during remaining 52 days it will total up to 49.0.
NovaBay Pharmaceuticals news expected interest is significantly higher compared to previous quarter (+inf%) and same quarter last year (+inf%).

YearQ1Q2Q3Q4
201938
118
210.5% QoQ
25
-78.8% QoQ
35
40.0% QoQ
2020 93
144.7% YoY 165.7% QoQ
184
55.9% YoY 97.8% QoQ
50
100.0% YoY -72.8% QoQ
117
234.3% YoY 134.0% QoQ
2021 64
-31.2% YoY -45.3% QoQ
18
-90.2% YoY -71.9% QoQ
99
98.0% YoY 450.0% QoQ
203
73.5% YoY 105.1% QoQ
2022 87
35.9% YoY -57.1% QoQ
46
155.6% YoY -47.1% QoQ
39
-60.6% YoY -15.2% QoQ
54
-73.4% YoY 38.5% QoQ
2023 0
-100.0% YoY -100.0% QoQ
34
-26.1% YoY inf% QoQ
107
174.4% YoY 214.7% QoQ
0
-100.0% YoY -100.0% QoQ
2024 21
inf% YoY inf% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and NovaBay Pharmaceuticals news search interestLast update: February 09 2024 20:09:45.
Correlation coefficient between keyword and revenue is 0.11
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 20:09:48.

The average 5 years interest of NovaBay Pharmaceuticals news was 5.49 per week.
The last year interest of NovaBay Pharmaceuticals news compared to the last 5 years has changed by -43.17%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -42.86%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 20:09:53.

After 39 days of this quarter the interest is at 36.0. Based on that we can calculate that during remaining 52 days it will total up to 84.0.
NovaBay Pharmaceuticals stock expected interest is significantly higher compared to same quarter last year (+inf%) but lower than previous quarter (-42.9%).

YearQ1Q2Q3Q4
201989
127
42.7% QoQ
92
-27.6% QoQ
51
-44.6% QoQ
2020 279
213.5% YoY 447.1% QoQ
203
59.8% YoY -27.2% QoQ
284
208.7% YoY 39.9% QoQ
95
86.3% YoY -66.5% QoQ
2021 233
-16.5% YoY 145.3% QoQ
75
-63.1% YoY -67.8% QoQ
85
-70.1% YoY 13.3% QoQ
26
-72.6% YoY -69.4% QoQ
2022 66
-71.7% YoY 153.8% QoQ
42
-44.0% YoY -36.4% QoQ
125
47.1% YoY 197.6% QoQ
114
338.5% YoY -8.8% QoQ
2023 0
-100.0% YoY -100.0% QoQ
102
142.9% YoY inf% QoQ
241
92.8% YoY 136.3% QoQ
147
28.9% YoY -39.0% QoQ
2024 36
inf% YoY -75.5% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and NovaBay Pharmaceuticals stock search interestLast update: February 09 2024 20:09:51.
Correlation coefficient between keyword and revenue is -0.19
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 20:09:54.

The average 5 years interest of NovaBay Pharmaceuticals stock was 9.62 per week.
The last year interest of NovaBay Pharmaceuticals stock compared to the last 5 years has changed by 5.2%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by 14.61%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for NBY
Earnings date: 2024-03-28 After close
Company name: Novabay Pharmaceuticals Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-03-23T12:30:00Z

GlobeNewswire
NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update

2025-11-18T15:28:08Z

Analyst Upgrades
Cloudflare Stumbled — And Tech Stocks Extend The Selloff

2025-10-20T23:07:28Z

GlobeNewswire
NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards

2025-10-20T08:47:58-04:00

SEC
8-K Form - Current report, items 1.01, 3.02, 3.03, 5.01, 5.02, 5.03, 5.07, and 9.01 - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)

2025-10-17T17:29:22-04:00

SEC
SCHEDULE 13D/A Form - [Amend] General Statement of Acquisition of Beneficial Ownership - NovaBay Pharmaceuticals, Inc. (0001389545) (Subject)

2025-10-17T17:28:33-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)

2025-10-17T17:10:52-04:00

SEC
SCHEDULE 13D/A Form - [Amend] General Statement of Acquisition of Beneficial Ownership - NovaBay Pharmaceuticals, Inc. (0001389545) (Subject)

2025-10-15T20:29:07-04:00

SEC
SCHEDULE 13D Form - General Statement of Acquisition of Beneficial Ownership - NovaBay Pharmaceuticals, Inc. (0001389545) (Subject)

2025-10-15T20:28:41-04:00

SEC
SCHEDULE 13D Form - General Statement of Acquisition of Beneficial Ownership - NovaBay Pharmaceuticals, Inc. (0001389545) (Subject)

2025-10-09T17:25:03-04:00

SEC
DEFA14A Form - Additional definitive proxy soliciting materials and Rule 14(a)(12) material - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)

2025-10-09T17:15:39-04:00

SEC
8-K Form - Current report, items 5.02 and 8.01 - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)

2025-10-03T17:12:05-04:00

SEC
S-3 Form - Registration statement under Securities Act of 1933 - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)

2025-09-23T16:30:57-04:00

SEC
DEF 14A Form - Other definitive proxy statements - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)

2025-09-23T16:30:03-04:00

SEC
ARS Form - Annual Report to Security Holders - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)

2025-09-18T16:33:35-04:00

SEC
8-K Form - Current report, items 7.01 and 9.01 - NovaBay Pharmaceuticals, Inc. (0001389545) (Filer)